Katherine J. Rowland

发表

Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and WNT.

Neno T Pokrajac, N. Tachibana, K. Aldape, 2020, The Journal of clinical investigation.

Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.

P. Brubaker, Katherine J. Rowland, P. Dubé, 2008, Endocrinology.

Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.

R. Kulkarni, M. Holzenberger, P. Brubaker, 2011, Gastroenterology.

Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts.

D. Storm, S. Heximer, A. Izzo, 2011, Endocrinology.

Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.

Gary D Bader, M. Tyers, M. Bernstein, 2016, Cancer cell.

Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells

N. Batada, M. Bernstein, S. Angers, 2019, Genes & development.

Life in the crypt: A role for glucagon-like peptide-2?

P. Brubaker, Katherine J. Rowland, 2008, Molecular and Cellular Endocrinology.

The "cryptic" mechanism of action of glucagon-like peptide-2.

P. Brubaker, Katherine J Rowland, Patricia L Brubaker, 2011, American journal of physiology. Gastrointestinal and liver physiology.

Role of the Intestinal Epithelial Insulin-like Growth Factor-1 Receptor in Glucagon-like Peptide-2-mediated Small Intestinal Growth Responses

Katherine J. Rowland, 2012 .

Glucagon-Like Peptide-2 Activates β-Catenin Signaling in the Mouse Intestinal Crypt: Role of Insulin-Like Growth Factor-I

P. Brubaker, Katherine J. Rowland, P. Dubé, 2008 .

High mortality in patients with chronic wounds

R. Kirsner, A. Vivas, J. Escandón, 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.

B. Yusta, D. Drucker, P. Brubaker, 2015, Cell metabolism.

The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.

C. Ackerley, M. Holzenberger, T. Gonska, 2014, Endocrinology.

Life in the crypt: A role for glucagon-like peptide-2?

P. Brubaker, Katherine J. Rowland, 2008, Molecular and Cellular Endocrinology.

The "cryptic" mechanism of action of glucagon-like peptide-2.

P. Brubaker, Katherine J. Rowland, 2011, American journal of physiology. Gastrointestinal and liver physiology.